Cayston Kit
Product Images NDC 61958-0901

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Cayston (NDC 61958-0901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cayston 01)

Chemical structure of the active ingredient aztreonam, showing its characteristic beta-lactam ring, side chains, and functional groups.*

FDA Label Image

Figure 1 (Cayston 02)

A line graph comparing FEV1 (lung function) changes over time for two groups: Placebo (N=84) and CAYSTON (aztreonam) (N=80). The x-axis shows days 0, 14, 28, and 42, with a shaded area highlighting the 28-day treatment period followed by 14 days of follow-up. The y-axis measures the adjusted mean change in FEV1 from baseline in liters, indicating increased lung function for the CAYSTON group during treatment compared to placebo.*

FDA Label Image

Figure 1 (Cayston 03)

Illustration showing the components of the Cayston kit, including the Altera Nebulizer System connected by tubing to a mouthpiece. Also depicted are a Cayston vial and two options for the saline solution: a saline ampoule or a saline vial.*

FDA Label Image

Figure 2a (Cayston 04)

An instructional diagram showing hands holding a vial with a rubber stopper. One hand is applying a label or strip with an arrow indicating placement direction onto the vial's side. The image appears to guide a step in kit preparation or drug labeling.*

FDA Label Image

Figure 2b (Cayston 05)

An instructional diagram showing hands removing the flip-off cap from a vial. The smaller inset illustrates the motion of lifting the cap upward and away from the vial's top, demonstrating how to open the vial correctly.*

FDA Label Image

Figure 2c (Cayston 06)

An instructional illustration showing a person holding a device component with one hand and rotating or twisting a part of it with the other hand, indicated by a curved arrow. The image appears to demonstrate a step in assembling or preparing a device or kit component, possibly related to Cayston (aztreonam) Kit.*

FDA Label Image

Figure 2d (Cayston 07)

An instructional diagram showing a lid being opened on a container or bottle. The image depicts the motion with an arrow indicating the direction to flip the cap open, demonstrating how to unlock or access the contents inside.*

FDA Label Image

Figure 3 (Cayston 08)

An instructional illustration showing a hand holding a saline ampule and dispensing drops into a vial, demonstrating the preparation process for the Cayston aztreonam kit.*

FDA Label Image

Figure 4 (Cayston 09)

An instructional illustration showing a hand administering drops of medication into the medication reservoir of a device with a labeled mouthpiece. The diagram highlights the medication reservoir and mouthpiece components for use in medication delivery.*

FDA Label Image

Figure 5 (Cayston 10)

Illustration showing how to align and insert the tab of a round device component into the tab slot of another device part, with an arrow indicating the directional rotation needed for assembly.*

FDA Label Image

Figure 6 (Cayston 11)

Illustration showing a person using a handheld nebulizer device, holding the mouthpiece to their lips and holding the device with one hand. The image appears to demonstrate the correct technique for inhalation using the nebulizer.*

FDA Label Image

Principal Display Panel (Cayston 28 Day Carton)

Packaging label for Cayston (aztreonam for inhalation solution) 75 mg/vial, a kit for oral inhalation only. The label indicates use exclusively with the Altera Nebulizer System and specifies a 28-day supply. It includes storage instructions recommending refrigeration at 2°C to 8°C. The labeler is Gilead Sciences, Inc., and the NDC is 61958-0901.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.